Navigation Links
Avexa Reports Positive Phase IIb Result

und 1.4 million people in North America and around 2.2 million people in Europe have HIV.

Once on therapy, patients with HIV will typically take a minimum of 3 drugs daily in combination. This may increase as a patient progresses into 2nd and 3rd line therapy or into salvage therapy, when patients develop what is commonly referred to as AIDS. Second line patients are defined as patients who show resistance to at least one class of HIV drugs, while 3rd line and salvage patients typically have resistance to multiple drugs and drug classes. Avexa aims to position ATC as the NRTI of choice for treatment of patients in 2nd and 3rd line therapy and salvage therapy, as well as the growing number of treatment naive patients presenting with HIV virus resistant to current front line therapies. In 2005 HIV drugs generated sales globally of USD $6.6 billion, with NRTIs representing greater than 50% of the overall market.

Avexa Limited is a Melbourne-based biotechnology company with a focus on research and development of drugs for the treatment of infectious diseases, in particular diseases which have a significant unmet medical need. Avexa has dedicated resources and funding for key projects including antiviral drugs for HIV and an antibiotic alternative for antibiotic-resistant bacterial infections. The Company's lead program is apricitabine (ATC) which has recently successfully completed the 21 day dosing of its Phase IIb trial. The Company continues to progress ATC towards Phase III trials.

Technical Data

Trial Design

AVX-201 is a randomised, double blind study of two doses of ATC compared to lamivudine (3TC) in treatment-experienced HIV-1 infected patients with the M184V mutation. Patients were randomised to receive 600mg or 800mg ATC twice daily, or 3TC twice daily, for 21 days, in a blinded fashion. The primary endpoint of the study is the change in the amount of virus in the blood (viral load) after 21 days treatment.

After day 2
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avexas Apricitabine Clinical Trial Update
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Avexa Reports Positive Phase IIb Result
(Date:8/4/2015)... Pa. , Aug. 4, 2015 Among ... prescription medications, yet only half of consumers surveyed are ... percent have ever used use them, according to findings ... , a community service partnership focused on improving the ... The online survey polled 1,000 men and women, ...
(Date:8/3/2015)... Aug. 3, 2015  BC Technical, the nation,s leading non-OEM ... Medical Systems, one of the largest MRI service providers ... Ohio Valley Medical Systems allows BC Technical to expand ...   "We couldn,t be more excited about ... CEO of BC Technical. "The Ohio Valley engineers are ...
(Date:8/3/2015)... Calif., Aug. 3, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... update and reported financial results for the three and ... highlights include: , On July 23, 2015, the ... a positive opinion for Zalviso™ for the management of ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3BC Technical Acquires Ohio Valley Medical Systems 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10
(Date:8/4/2015)... View, CA (PRWEB) , ... August 04, 2015 ... ... Surgeon General of the United States, Richard Carmona, M.D., M.P.H., FACS, to its ... catastrophic medication errors and will save lives," Dr. Carmona said. "I strongly believe ...
(Date:8/4/2015)... Nevada (PRWEB) , ... August 04, 2015 , ... One ... radio interviews to discuss his new book, The Pain Antidote , which provides ... Director of Las Vegas Recovery Center’s Chronic Pain Treatment Program, wrote the book in ...
(Date:8/4/2015)... ... August 04, 2015 , ... Buckeye Health Plan is ... required immunizations are covered for members under the Healthchek program . , ... up with their immunizations may not be allowed to attend when school begins ...
(Date:8/4/2015)... Beverly Hills, CA (PRWEB) , ... August 04, ... ... a personal consultation complete with full examination now offered by the world renowned ... a more beautiful aesthetic facial appearance through cosmetic surgery techniques helps individuals to ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics heaven,” ... customer experience inside Naimie’s Beauty Center in LA. Now MENAJI is part of that ... better. , Naimie’s Beauty Center has been a favorite of makeup artists and hair ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:MENAJI Shines in Make-Up Mecca for Stars 2
... ... for the benefit of the community through various events and initiatives. For example, on June ... provider to the Round Rock Express, to support to the Round Rock Express AAA Minor ... Austin, ...
... reform proposals now before Congress could help the more ... coverage, and such reforms would also help ensure that ... according to a new Commonwealth Fund report. Extending health ... and a health insurance exchange with a choice of ...
... , , THE WOODLANDS, Texas, Aug. ... Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US ... Dale Ross is retiring as Executive Chairman and from the Board ... President, will also become Chairman of the Board. , , ...
... , , , ... Nationwide Health Properties, Inc. (NYSE: NHP ) today announced results ... Contemporaneously with this press release, the Company filed its Quarterly Report on ... and Exchange Commission. , , "NHP,s strong balance ...
... 5 Select Medical Corporation ("Select") and Select,s parent ... 2009 entered into Amendment No. 3 (the "Amendment") to ... 24, 2005 (as amended to date, the "Credit Facility"), ... loans and JPMorgan Chase Bank, N.A., as administrative agent. ...
... , , , Analysis ... , , WASHINGTON, Aug. 5 United ... Report ( www.ucp.org/medicaid ), ranking all 50 states ... provide to their Mental Retardation/Developmental Disability populations. The report ...
Cached Medicine News:Health News:HealthYes! Provides Free Preventive Screening in Support of Round Rock Express 2Health News:HealthYes! Provides Free Preventive Screening in Support of Round Rock Express 3Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 3Health News:US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board 2Health News:US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board 3Health News:US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board 4Health News:US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board 5Health News:NHP Reports 2009 Second Quarter Results 2Health News:NHP Reports 2009 Second Quarter Results 3Health News:NHP Reports 2009 Second Quarter Results 4Health News:NHP Reports 2009 Second Quarter Results 5Health News:NHP Reports 2009 Second Quarter Results 6Health News:NHP Reports 2009 Second Quarter Results 7Health News:NHP Reports 2009 Second Quarter Results 8Health News:NHP Reports 2009 Second Quarter Results 9Health News:NHP Reports 2009 Second Quarter Results 10Health News:NHP Reports 2009 Second Quarter Results 11Health News:NHP Reports 2009 Second Quarter Results 12Health News:NHP Reports 2009 Second Quarter Results 13Health News:NHP Reports 2009 Second Quarter Results 14Health News:NHP Reports 2009 Second Quarter Results 15Health News:NHP Reports 2009 Second Quarter Results 16Health News:NHP Reports 2009 Second Quarter Results 17Health News:NHP Reports 2009 Second Quarter Results 18Health News:NHP Reports 2009 Second Quarter Results 19Health News:Select Medical Corporation Amends its Senior Secured Credit Facility 2Health News:4th Annual Case for Inclusion Report Ranks All 50 States on Community-Based Support 2
... centrifuge is designed especially for ... cover with safety interlock switch, ... emissions, "hold" position for continuous ... motor, maximum stability and compact, ...
... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
... lens handle lets them hold the ... itself. Lenses and tints are shown ... white with literature holders on each ... black, red, or white marble, gray ...
Medicine Products: